Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
about
Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studiesScreen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signalingp53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress.Acetyl-l-carnitine and oxfenicine on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar ratsTreatment of refractory anginaThermal tomography imaging in photonic traditional Chinese medicine information therapy with holistic effect for health whole nursingDynamic analysis of optimality in myocardial energy metabolism under normal and ischemic conditionsA proteomic study of Shengmai injection's mechanism on preventing cardiac ischemia-reperfusion injury via energy metabolism modulation.Therapeutic targeting of HES1 transcriptional programs in T-ALLC-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes.Metabolic modulators for chronic cardiac ischemia.Metabolic therapeutics in angina pectoris: history revisited with perhexiline.Ranolazine, a novel agent for chronic stable angina.Mitochondria as a drug target in ischemic heart disease and cardiomyopathySteady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineTaking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.Overview of emerging pharmacotherapy in chronic heart failure.Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.Snf1-related kinase improves cardiac mitochondrial efficiency and decreases mitochondrial uncoupling.Magnetic resonance spectroscopy in myocardial disease.Efficacy of metabolic modulators in ischemic heart disease: an overview.Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents.Cardiovascular effects of incretin-based therapies.Cardioprotective effects of incretin during ischaemia-reperfusion.Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.Antagonist molecules in the treatment of anginaGood and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models.Heart failure: novel therapeutic approaches.Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich's ataxia cardiomyopathy modelPleiotropic mechanisms of action of perhexiline in heart failure.Emerging drugs for the treatment of angina pectoris.Refractory myocardial ischemic syndromes: patients' characterization and treatment goals.Effect of Mobile Phone Radiation on Cardiovascular Development of Chick Embryo.Liver Effects of Clinical Drugs Differentiated in Human Liver Slices.Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy - Six months follow-up result.Myocardial metabolic manipulation: a new therapeutic approach in heart failure?Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors.Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial.[Cardiovascular effects of incretin-based therapies].
P2860
Q26746907-4A691E2A-0AF0-490C-AFBD-4B487F25B82AQ28476186-4D607A95-B9C2-4101-A3E9-6EE32CBC5C95Q29347283-BD41D2D1-A039-495C-BF4B-C7D8A01B50DFQ34905231-B088C773-2DFB-454F-8560-52DE5A70024CQ34986448-C79C20EC-7D00-4756-BC1B-3C707B80568AQ35187789-92448397-A193-40CC-87B5-068C5F661A7BQ35193508-715D22BF-8B2E-4BA8-9473-E918BA1B6469Q35452821-A0AE4C06-A471-4D91-81F8-104BA1014C89Q35584248-F295E760-E043-4048-B275-73D51102D503Q35859423-3CDFDFEE-B698-416D-BF77-F00E02DE3843Q36355273-722FD745-4165-4E1B-AF06-8E1B44731FD4Q36392401-C8CBD48C-D2FB-4F79-9723-002FDB8F1994Q36408751-D70480A7-9966-4B23-ABBB-B6F413EDA88FQ36426316-C1F81F7E-2F89-49C3-BF28-788254F52C0FQ36535908-4EA70E27-ADB0-410C-9AED-F076FB521D7AQ37457580-E843EDE0-64C1-4F72-8C94-B1EA9CAB07B7Q37552943-28569EA4-A883-4990-8AC9-375812204941Q37603719-09B66B0C-9FB7-4BA4-A4E1-AA9F86CDD3CDQ37617873-E3607222-A1F8-433F-A016-17EFF837EDA5Q37688176-593A95D1-2E3A-4DB6-9556-2E373A4F6EC1Q37850633-2B7A2809-418C-4A4B-8B05-63E3884EEDA9Q37858515-7E8495B0-FE67-4A93-AE5A-A15E4F948FE3Q37977336-66FD6E76-CC8A-4EA4-8D1A-FA61FD9042CAQ38002006-724E2212-237F-4BAD-8BEA-AABEAD110657Q38057398-578B59E3-EE24-48CD-BCDB-6C0E5AD8402EQ38139089-D90BE0D0-E97C-403F-8372-25EF207860BBQ38375945-A4668972-DB40-46B0-B391-20C1040A4262Q38376055-E43F7087-2EB5-4EF1-9361-09F8A93E083BQ38671402-77D402E2-C9B1-4F1D-9130-3C6861B91B2DQ38907804-33C36E69-83EA-40A7-BA81-C514D7609AD7Q38967994-88D4BDD5-356F-41C8-95F3-4BDCB134E6F7Q40393647-8DEAECE0-DADA-445B-BDB5-9189BA444B1BQ40740580-5A8F9586-27EC-4271-81FC-2E6B4EAD2F76Q41951728-C5AD942B-DBDB-4A76-9D09-5BC61665F9CFQ42837522-6C46E065-2D2B-4863-A7F7-95654AE557D1Q43012953-0EFD9736-8F18-4E19-9E2E-F3773713BB07Q44255490-255859A0-824C-46F6-83C4-FE0F01ED7682Q46713286-083A4063-94B6-4387-9237-CBE4F3B772B5Q53257055-FEC101C9-09C6-47B4-B174-38C9C5B018BCQ54522495-04C26272-C8A7-4F8C-9317-B5EEB93489A4
P2860
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
@ast
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
@en
type
label
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
@ast
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
@en
prefLabel
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
@ast
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
@en
P2093
P1476
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
@en
P2093
John Horowitz
Michael Frenneaux
P304
P356
10.1016/J.EHJ.2004.02.018
P577
2004-04-01T00:00:00Z